NDC 64232-045

CandiRoqSAN

Candida Parapsilosis And Penicillium Roqueforti

CandiRoqSAN is a Rectal Suppository in the Human Otc Drug category. It is labeled and distributed by Sanpharma Gmbh. The primary component is Candida Parapsilosis; Penicillium Roqueforti.

• Product ID: 64232-045_883798be-288a-056e-e053-2995a90a6dc7
• NDC: 64232-045
• Product Type: Human Otc Drug
• Proprietary Name: CandiRoqSAN
• Generic Name: Candida Parapsilosis And Penicillium Roqueforti
• Dosage Form: Suppository
• Route of Administration: RECTAL
• Marketing Start Date: 2017-01-07
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: sanPharma GmbH
• Substance Name: CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI
• Active Ingredient Strength: 3 [hp_X]/1; [hp_X]/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 64232-045-17

2 BLISTER PACK in 1 BOX (64232-045-17) > 5 SUPPOSITORY in 1 BLISTER PACK

• Marketing Start Date: 2017-01-07
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 64232-045-17 [64232004517]

CandiRoqSAN SUPPOSITORY

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2017-01-07
• Marketing End Date: 2019-12-10

Drug Details

Active Ingredients

Ingredient	Strength
CANDIDA PARAPSILOSIS	3 [hp_X]/1

OpenFDA Data

• SPL SET ID: 4559a541-0ee7-48ea-bfe0-77403148458d
• Manufacturer:
  • sanPharma GmbH
• UNII:
  • 0KZ676D44N
  • 7ORP6R724L